KR20020035131A - 덱스라족산의 건선 치료 용도 - Google Patents

덱스라족산의 건선 치료 용도 Download PDF

Info

Publication number
KR20020035131A
KR20020035131A KR1020027003049A KR20027003049A KR20020035131A KR 20020035131 A KR20020035131 A KR 20020035131A KR 1020027003049 A KR1020027003049 A KR 1020027003049A KR 20027003049 A KR20027003049 A KR 20027003049A KR 20020035131 A KR20020035131 A KR 20020035131A
Authority
KR
South Korea
Prior art keywords
acid
injection
medicament
psoriasis
dexlazan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020027003049A
Other languages
English (en)
Korean (ko)
Inventor
차르마니안이어반트
로간-그르가스야드란카
Original Assignee
시아투스 엑스크비레레 파마포르슝스 게엠베하
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 시아투스 엑스크비레레 파마포르슝스 게엠베하 filed Critical 시아투스 엑스크비레레 파마포르슝스 게엠베하
Publication of KR20020035131A publication Critical patent/KR20020035131A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020027003049A 1999-09-10 2000-09-08 덱스라족산의 건선 치료 용도 Withdrawn KR20020035131A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AT155899 1999-09-10
ATA1558/99 1999-09-10
US18380600P 2000-02-22 2000-02-22
US60/183,806 2000-02-22
PCT/EP2000/008879 WO2001019358A2 (en) 1999-09-10 2000-09-08 Use dexrazoxane for treating psoriasis

Publications (1)

Publication Number Publication Date
KR20020035131A true KR20020035131A (ko) 2002-05-09

Family

ID=25596169

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020027003049A Withdrawn KR20020035131A (ko) 1999-09-10 2000-09-08 덱스라족산의 건선 치료 용도

Country Status (16)

Country Link
EP (1) EP1214073A2 (cs)
KR (1) KR20020035131A (cs)
CN (1) CN1378451A (cs)
AU (1) AU7286500A (cs)
BG (1) BG106428A (cs)
BR (1) BR0013921A (cs)
CA (1) CA2384685A1 (cs)
CZ (1) CZ2002729A3 (cs)
EE (1) EE04871B1 (cs)
HR (1) HRPK20020201B1 (cs)
HU (1) HUP0202791A3 (cs)
MX (1) MXPA02002486A (cs)
PL (1) PL354980A1 (cs)
RU (1) RU2002106874A (cs)
SK (1) SK2802002A3 (cs)
WO (1) WO2001019358A2 (cs)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021053523A1 (en) * 2019-09-18 2021-03-25 Tryp Therapeutics Compositions and methods to improve the therapeutic benefit of bis-dioxopiperazines
WO2023182298A1 (ja) 2022-03-22 2023-09-28 国立大学法人京都大学 脆弱ｘ症候群の治療または予防薬

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3941790A (en) * 1967-07-03 1976-03-02 National Research Development Corporation Bis diketopiperazines
GB1234935A (en) * 1967-07-03 1971-06-09 Nat Res Dev Piperazine derivatives
US4963679A (en) * 1988-02-17 1990-10-16 Erbamont, Inc. Process for preparing bis (3,5-dioxopiperazinyl) alkanes or alkenes
BR9407145A (pt) * 1993-07-23 1996-09-17 Lxr Biotechnologie Inc Métodos para tratar apoptose e condições associadas

Also Published As

Publication number Publication date
WO2001019358A3 (en) 2001-10-04
EE200200128A (et) 2003-04-15
BG106428A (en) 2003-04-30
PL354980A1 (en) 2004-03-22
SK2802002A3 (en) 2003-02-04
EP1214073A2 (en) 2002-06-19
MXPA02002486A (es) 2004-09-10
HUP0202791A2 (hu) 2003-01-28
EE04871B1 (et) 2007-08-15
HUP0202791A3 (en) 2003-02-28
WO2001019358A2 (en) 2001-03-22
HRPK20020201B1 (en) 2004-08-31
CN1378451A (zh) 2002-11-06
BR0013921A (pt) 2002-05-14
CA2384685A1 (en) 2001-03-22
AU7286500A (en) 2001-04-17
RU2002106874A (ru) 2003-11-20
HRP20020201A2 (en) 2003-06-30
CZ2002729A3 (cs) 2002-07-17

Similar Documents

Publication Publication Date Title
EP0391905B1 (en) Use of disaccharide polysulfate-aluminium compound in the manufacture of a medicament for treating HEMORRHOIDs and for wound healing
EP0506658B1 (en) Compositions and method for treating painful, inflammatory or allergic disorders
WO1993000873A1 (en) Composition and method for transdermal delivery of diclofenac
JPH0216728B2 (cs)
JPS62246515A (ja) タモキシフエン又はその製薬上認容性塩を含有する乾癬の治療剤
US4369190A (en) Analgesic composition and use thereof to ameliorate intractable pain
JPH01501627A (ja) 乾癬治療用組成物
US11963991B2 (en) Treatment of warts
US6613800B1 (en) Method and compositions for treating psoriasis, eczema, seborrhea and arthritis
WO2024239066A1 (en) Pharmaceutical composition
US5128375A (en) Keloid treating agent
US5576329A (en) Method for treating tendon or joint inflammation with papaverine HCL
JPH06199672A (ja) 活性成分としてクロラムフェニコール、ゲンタマイシンおよびナイスタチンを含有する、炎症性皮膚疾患の局所治療のための配合製剤
KR20020035131A (ko) 덱스라족산의 건선 치료 용도
US6693100B1 (en) Pharmaceutical compositions for treating psoriasis
US5556871A (en) Method for treating epithelial precancerous lesions with topical inidazoles
US20030072828A1 (en) Natural therapeutic composition for the treatment of wounds and sores
US12440526B2 (en) Treatment of warts
RU1811846C (ru) Способ лечени рожистого воспалени
HK40054772B (en) Treatment of warts
HK40054772A (en) Treatment of warts
VANDER VEER et al. Clinical experiences with a new mercurial diuretic for subcutaneous administration
JPS63179825A (ja) 局所抗炎症剤
JPH03258715A (ja) 消炎鎮痛外用剤

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20020307

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid